Iron overload is common in patients undergoing allogeneic hematopoietic cell transplantation (HCT), but the mechanisms leading to overload are unknown. Here, we determined iron levels and the expression of iron regulatory proteins in the liver and gut of NOD/SCID mice transplanted with syngeneic (histocompatible) or allogeneic (histoincompatible) T lymphocytes.
Introduction
Iron overload is common in patients undergoing hematopoietic cell transplantation (HCT). [1] [2] [3] Many of these patients develop iron overload even without heavy red cell transfusion support; the mechanisms are largely unknown. High-dose conditioning preceding HCT may result in hyperferremia and increased non-transferrin-bound iron, in association with the cessation of erythropoietic activity. 4, 5 In many patients hyperferremia persists after HCT, 1,2 suggesting aberrant iron release into the circulation.
The major regulator of iron release into the circulation is hepcidin (Hamp), secreted mainly by the liver. 6 Hepcidin binds to the iron transporter ferroportin 1 (Fpn), expressed on enterocytes and macrophages, which delivers iron from inside the cell to the circulation. 7 Hepcidin binding results in internalization and cytoplasmic degradation of ferroportin. As both the intestinal tract and liver are targets of graft-versus-host disease (GVHD), 2, 8, 9 we hypothesized that one effect of allogeneic transplantation may be direct or indirect interference by T lymphocytes with the expression or function of iron regulatory proteins in liver and gut, thereby contributing to iron overload. Here we characterized Hamp and Fpn expression and dietary iron uptake in a murine model of histoincompatible allogeneic T lymphocyte transplantation.
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Materials and Methods
Female NOD/LtSz-scid/scid (NOD/SCID [H-2d]), C57BL/6J (H-2b), and BALB/cJ mice (H-2d) were purchased from Jackson Laboratories (Bar Harbor, ME). NOD/SCID mice were maintained in a pathogen-free environment and kept on normal chow (iron content ~35 ppm) or chow with Mice were euthanized at 7 or 14 days post-transplant (3-6 weeks after initiating a particular diet) by CO 2 inhalation. Blood was collected via cardiac puncture and total serum iron was measured. Hepatic iron content was determined using a colorimetric assay as described. 10 Tissue for histology was fixed in 10% formalin and embedded in paraffin. Sections were stained with hematoxylin and eosin and with Perl's Prussian blue to detect iron deposition.
Hepatocyte suspensions were generated by mincing and straining liver tissue through a 75 μm mesh. Enterocytes were obtained by scraping the mucosa off the inverted duodenum and mincing and straining through a 75 μm mesh. Total RNA was isolated and cDNA synthesized using the μ MACS One-Step cDNA Synthesis kit (Miltenyi Biotec, Auburn, CA) as instructed and as previously described. 11 Quantitative-PCR was carried out using the comparative C t 
Results and Discussion
NOD/SCID mice were used to allow for engraftment of donor cells without cytotoxic conditioning of the recipient, which could induce interleukin (IL)-6 and affect regulation of hepcidin. In NOD/SCID mice fed normal chow and infused with 3.0×10 7 histoincompatible T lymphocytes, liver sections obtained on day 14 showed iron deposition in hepatocytes ( Figure   1A ). In contrast, no iron deposition was observed in mice infused with histocompatible syngeneic T cells or in control mice not given T lymphocytes ( Figure 1A ). Quantitative analysis of liver tissue confirmed elevated levels of hepatic iron in mice transplanted with histoincompatible T cells ( Figure 1B ). Mice given histoincompatible T-cells also showed histological evidence of injury of the gut mucosa ( Figure 1C ) and the liver ( Figure 1D ), Figure 1E ). Control mice showed slight increases in body weight over 14 days, whereas the weight declined progressively in mice given histoincompatible T cells, as classically observed in murine GVHD. 15 The weight loss was prevented or reversed in mice pre-treated with apoTf ( Figure 1F ). We had shown previously that Fas-initiated hepatocyte injury was attenuated or prevented by apotransferrin. 13, 16 Since alloactivated T lymphocytes express Fas-ligand, and Fas signaling is involved in GVHD, 17, 18 we postulated that pre-treatment of NOD/SCID mice with apotransferrin before histoincompatible T-cell infusion would interfere with hepatic injury and liver iron deposition. Results illustrated in Responses differed strikingly in mice infused with histoincompatible allogeneic T
lymphocytes. While mice transplanted with histocompatible syngeneic T cells showed a pattern
For personal use only. on October 22, 2017. by guest www.bloodjournal.org From 7 of serum iron levels, and hepcidin and Fpn expression that was similar to that in mice not injected with T lymphocytes, the infusion of histoincompatible T cells resulted in significant dysregulation: mice on all diets showed significant increases in serum iron levels, which was most marked in mice on high iron diet (p< 0.001; Figure 2A ). Fpn expression in the duodenal mucosa increased 10-100-fold following the infusion of allogeneic cells, even in mice on high iron diet ( Figure 2B ). Upregulation of Fpn message was reflected in enhanced expression of Fpn protein in enterocytes, as illustrated in Figure 2D . Conversely, Hamp expression in the liver declined consistently, including mice on high iron diet and documented liver iron overload 
